Ethyl (2Z)-2-(2-dodecyl-1,1-dioxo-3H-1λ6,2-benzothiazin-4-ylidene)acetate
C24H37NO4S — CID 24793511
Data last refreshed: (MolForge compound catalog, from PubChem)
About Ethyl (2Z)-2-(2-dodecyl-1,1-dioxo-3H-1λ6,2-benzothiazin-4-ylidene)acetate
Ethyl (2Z)-2-(2-dodecyl-1,1-dioxo-3H-1λ6,2-benzothiazin-4-ylidene)acetate (PubChem CID 24793511) has the molecular formula C24H37NO4S and a molecular weight of 435.63 g/mol. Its IUPAC name is ethyl (2Z)-2-(2-dodecyl-1,1-dioxo-3H-1λ6,2-benzothiazin-4-ylidene)acetate.
Molecular Properties
| Compound Name | Ethyl (2Z)-2-(2-dodecyl-1,1-dioxo-3H-1λ6,2-benzothiazin-4-ylidene)acetate |
|---|---|
| PubChem CID | 24793511 |
| Molecular Formula | C24H37NO4S |
| Molecular Weight | 435.63 g/mol |
| Exact Mass | 435.24 |
| IUPAC Name | ethyl (2Z)-2-(2-dodecyl-1,1-dioxo-3H-1λ6,2-benzothiazin-4-ylidene)acetate |
| SMILES | CCCCCCCCCCCCN1C/C(=C\C(=O)OCC)c2ccccc2S1(=O)=O |
| InChI | InChI=1S/C24H37NO4S/c1-3-5-6-7-8-9-10-11-12-15-18-25-20-21(19-24(26)29-4-2)22-16-13-14-17-23(22)30(25,27)28/h13-14,16-17,19H,3-12,15,18,20H2,1-2H3/b21-19+ |
| InChIKey | HKOWNLJYZLCNQL-XUTLUUPISA-N |
| XLogP | 5.56 |
| TPSA | 63.68 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 13 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 435.63 |
| LogP ≤ 5 | 5.56 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 4 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 24793511 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.